Spinnaker Biosciences

Spinnaker Biosciences Develops Contrast Agents for Nanoporous Silicon Particles Used in Controlled-Release Drug DeliverySpinnaker Biosciences' process allows for the fabrication of nanopores precisely tuned to accommodate the size of the target drug, providing a protective cage for the drug while controlling its release rate and particle dissolution. This enables healthcare professionals to develop composite materials for manufacturing controlled-release drug delivery carriers.